Publication:
A novel agent for myeloma causing toxic keratopathy, belantamab mafodotin: a case report and literature review

Thumbnail Image

Departments

Organizational Unit

School / College / Institute

Organizational Unit
SCHOOL OF MEDICINE
Upper Org Unit

Program

KU-Authors

KU Authors

Co-Authors

Kurt, Rengin Aslıhan
Gören, Deniz
Karadeniz, Sehnaz
Arat, Mutlu

Publication Date

Language

Type

Embargo Status

Journal Title

Journal ISSN

Volume Title

Alternative Title

Belantamabe-mafodotina, um novo agente para mieloma, causando ceratopatia tóxica: relato de caso e revisão da literatura

Abstract

A 60-year-old-male with refractory relapsed multiple myeloma presented with redness, pain, foreign body sensation, and blurred vision in both eyes that gradually increased after his third belantamab mafotodin infusion. Biomicroscopy revealed bilateral microcyst-like epithelial changes and epithelial crystal-like deposits, whereas in vivo confocal microscopy revealed intraepithelial and subepithelial hyperreflective deposits in corneal epithelium. Belantamab mafodotin therapy was discontinued for seven weeks due to corneal toxicity, which cleared progressively. We aim to demonstrate belantamab mafodotin-related corneal toxicity that may be detected using slit lamp and in vivo confocal biomicroscopy. © This content is licensed under a Creative Commons Attributions 4.0 International License.

Source

Publisher

Conselho Brasileiro de Oftalmologia

Subject

Ophthalmology

Citation

Has Part

Source

Arquivos Brasileiros de Oftalmologia

Book Series Title

Edition

DOI

10.5935/0004-2749.2021-0358

item.page.datauri

Link

Rights

Copyrights Note

Endorsement

Review

Supplemented By

Referenced By

6

Views

3

Downloads

View PlumX Details